Cite
HARVARD Citation
Dumont, S. et al. (n.d.). 2022-RA-884-ESGO Whole-body diffusion-weighted MRI (WB-DWI/MRI) for the prediction of resectable disease at the time of secondary cytoreductive surgery for relapsed epithelial ovarian cancer. International journal of gynecological cancer. pp. A273-A274. [Online].